Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform, developed in collaboration with Geisinger. The platform provides clinicians…
Read MoreUse of artificial intelligence to tackle coronavirus must go through ethical checks, say experts
Rapid deployment of artificial intelligence and machine learning to tackle coronavirus must still go through ethical checks and balances, or we risk harming already disadvantaged communities in the rush to defeat the disease. This is according to researchers at the…
Read MoreAn Epic cognitive computing platform primer
In production machine learning systems, the model itself is only a small part of the implementation. The “scaffolding” required to run machine learning models, also called machine learning operations or MLOps, is another crucial component. This scaffolding includes configuration, data…
Read MoreMIT researchers use AI to find drugs that could be repurposed for COVID-19
The Massachusetts Institute of Technology announced this week that researchers had used machine learning to identify medications that may be repurposed to fight COVID-19. “Making new drugs takes forever,” Caroline Uhler, a computational biologist in MIT’s Department of Electrical…
Read MorePeople with dementia found to have significantly increased risk for COVID-19
A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19-;and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults…
Read MoreIsrael to share data with Pfizer in exchange for COVID-19 vaccine doses
Israel has committed to send Pfizer statistical data and details in exchange for COVID-19 vaccine doses. Prime minister Benjamin Netanyahu announced he had secured a deal with the pharma company which will enable all citizens of Israel aged over 16…
Read MoreAI-powered solutions in tackling COVID-19 and beyond
After experiencing two winters, Artificial Intelligence (AI) is increasingly driving developments in technology and businesses, from autonomous vehicles to medical diagnosis, moving AI from theory to commercial applications. These innovative applications are increasingly important and becoming more prevalent in society….
Read MoreGreat Ormond Street Hospital for Children NHS FT awarded Stage 7 O-EMRAM
Great Ormond Street Hospital for Children NHS FT (GOSH) in London has been awarded Stage 7 on the O-EMRAM by HIMSS this week, making it the first hospital in England to achieve the validation. O-EMRAM, or the Outpatients Electronic Medical…
Read MorePittsburgh Health Data Alliance developing new AI models for oncology, mental health
More than a year since they announced a partnership to advance machine learning advancement in areas such as oncology, precision medicine and imaging, the researchers from the Pittsburgh Health Data Alliance and AWS are unveiling new AI-based techniques to assess breast cancer risk,…
Read MoreMedical AI solutions company VUNO obtains CE Mark for five of its solutions
Founded in South Korea in 2014, medical AI solutions development company VUNO announced that they have received the Class IIa CE markings for five of their AI solutions. The five CE marked solutions are: VUNO Med –BoneAge – VUNO’s first…
Read More